Artificial Intelligence in Organoid-Based Disease Modeling: A New Frontier in Precision Medicine
Biomimetics · 17.12.2025 · 10 (12) · 845
DOI: 10.3390/biomimetics10120845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomimetics, online erschienen am 17.12.2025. Verfasst von Omar Balkhair und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Organoids are self-organizing three-dimensional (3D) cellular structures derived from stem cells. They can mimic the anatomical and functional properties of real organs. They have transformed in vitro disease modeling by closely replicating the structural and functional characteristics of human tissues. The complexity and variability of organoid-derived data pose significant challenges for analysis and clinical translation. Artificial Intelligence (AI) has emerged as a crucial enabler, offering scalable and high-throughput tools for interpreting imaging data, integrating multi-omics profiles, and guiding experimental workflows. This review aims to discuss how AI is reshaping organoid-based research by enhancing morphological image analysis, enabling dynamic modeling of organoid development, and facilitating the integration of genomics, transcriptomics, and proteomics for disease classification. Moreover, AI is increasingly used to support drug screening and personalize therapeutic strategies by analyzing patient-derived organoids. The integration of AI with organoid-on-chip systems further allows for real-time feedback and physiologically relevant modeling. Drawing on peer-reviewed literature from the past decade, Furthermore, CNNs have been used to analyze colonoscopy and histopathological images in colorectal cancer with over 95% diagnostic accuracy. We examine key tools, innovations, and case studies that illustrate this evolving interface. As this interdisciplinary field matures, the future of AI-integrated organoid platforms depends on establishing open data standards, advancing algorithms, and addressing ethical and regulatory considerations to unlock their clinical and translational potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
- Department of Human and Clinical Anatomy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman.
ORCID-Profile: Omar Balkhair, Halima Albalushi
Zitieren
APA
Balkhair, O., & Albalushi, H. (2025). Artificial Intelligence in Organoid-Based Disease Modeling: A New Frontier in Precision Medicine. Biomimetics, 10(12), 845. https://doi.org/10.3390/biomimetics10120845
Vancouver
Balkhair O, Albalushi H. Artificial Intelligence in Organoid-Based Disease Modeling: A New Frontier in Precision Medicine. Biomimetics. 2025;10(12):845. doi:10.3390/biomimetics10120845
BibTeX
@article{Balkhair2025,
author = {Balkhair, Omar and Albalushi, Halima},
title = {Artificial Intelligence in Organoid-Based Disease Modeling: A New Frontier in Precision Medicine},
journal = {Biomimetics},
year = {2025},
volume = {10},
number = {12},
pages = {845},
doi = {10.3390/biomimetics10120845}
}
EUVIMED